Related Experiment Videos
Congenital posterolateral diaphragmatic hernia: a retrospective study
Canadian Journal of Surgery. Journal Canadien De Chirurgie
|September 1, 1981
Summary
Congenital posterolateral diaphragmatic hernia (CDH) has high mortality due to ventilatory failure. Survival depends on factors like lung hypoplasia and timely intervention, with vasodilators showing potential therapeutic value.
Area of Science:
- Pediatric Surgery
- Neonatal Medicine
- Pulmonology
Background:
- Congenital posterolateral diaphragmatic hernia (CDH) presents a significant challenge in neonatology.
- Ventilatory failure is a primary cause of mortality in infants with CDH.
Purpose of the Study:
- To evaluate malformation and survival factors in neonatal CDH.
- To assess the impact of associated anomalies and timing of admission on CDH outcomes.
Main Methods:
- Retrospective study of 43 neonates diagnosed with CDH.
- Analysis of survival rates, associated anomalies, and autopsy findings.
- Evaluation of tolazoline use as a potential vasodilator therapy.
Main Results:
- 20 out of 43 neonates survived.
- Ventilatory failure and severe bilateral lung hypoplasia were common in non-survivors.
- Early admission (within 8 hours) was noted in most deceased infants.
- Tolazoline use in 10 patients resulted in 4 survivors.
Conclusions:
- Congenital diaphragmatic hernia survival is significantly impacted by ventilatory failure and lung hypoplasia.
- Early detection and intervention are crucial for improving CDH outcomes.
- Vasodilator therapy, such as tolazoline, may offer a promising avenue for future treatment strategies in CDH.